Company Search:
Advanced Search
Sponsored Links
Nel ASA Company Snapshot
Nel ASA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nel ASA with three other miscellaneous service companies in Europe: Circassia Pharmaceuticals PLC of the United Kingdom (2015 sales of £10.80 million [US$13.17 million] of which 95% was operating-NIOX), Pharming Group NV of the Netherlands (10.83 million Euro [US$11.80 million] ), and Thrombogenics Nv which is based in Belgium (11.20 million Euro [US$12.20 million] of which 100% was Royalty Income).

Sales Analysis. Sales increased substantially in 2015: Nel ASA reported sales of NOK 99.93 million (US$12.06 million) for the year ending December of 2015. This represents an increase of 728.1% versus 2014, when the company's sales were NOK 12.07 million. This was the third consecutive year of growth at Nel ASA.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for Nel ASA
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 2.53
(Figures in Norwegian Kroner)
1 Week -2.7%   13 Weeks 8.6%  
4 Weeks 24.6%   52 Weeks 34.0%  
Nel ASA Key Data:
  Ticker: NEL Country: Norway
  Exchanges: OSL Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 99,925,130
(Year Ending Jan 2016).
Employees: 21
  Currency: Norwegian Kroner Market Cap: 1,729,705,978
  Fiscal Yr Ends: December Shares Outstanding: 683,678,252
  Share Type: Ordinaere Aksje Closely Held Shares: 285,043,138
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.